These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 6991217
21. Tolnaftate (tinactin), a new topical antifungal agent. Adam JE, Craig GE. Can Med Assoc J; 1965 Nov 06; 93(19):1004-5. PubMed ID: 5319027 [Abstract] [Full Text] [Related]
23. [Tried and newly expanded local therapy of mycoses]. Kohler J. Mykosen; 1968 May 01; 11(5):391-4. PubMed ID: 5711948 [No Abstract] [Full Text] [Related]
24. Haloprogin therapy for dermatophyte infections. Katz R, Cahn B. Arch Dermatol; 1972 Dec 01; 106(6):837-8. PubMed ID: 4565228 [No Abstract] [Full Text] [Related]
25. [Experiences with tinea pedis in daily practice]. Janke D. Arch Klin Exp Dermatol; 1966 Dec 01; 227(1):564-8. PubMed ID: 4383352 [No Abstract] [Full Text] [Related]
31. [The treatment of dermatomycoses with Phebrocon]. Bossong W. Z Haut Geschlechtskr; 1969 Dec 01; 44(23):979-90. PubMed ID: 4248599 [No Abstract] [Full Text] [Related]
32. Sertaconazole nitrate cream 2% for the treatment of tinea pedis. Ribotsky BM. Cutis; 2009 May 01; 83(5):274-7. PubMed ID: 19537285 [Abstract] [Full Text] [Related]
33. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study. Budimulja U, Bramono K, Urip KS, Basuki S, Widodo G, Rapatz G, Paul C. Mycoses; 2001 May 01; 44(7-8):300-6. PubMed ID: 11714065 [Abstract] [Full Text] [Related]
34. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. Ortonne JP, Korting HC, Viguié-Vallanet C, Larnier C, Savaluny E. J Eur Acad Dermatol Venereol; 2006 Nov 01; 20(10):1307-13. PubMed ID: 17062050 [Abstract] [Full Text] [Related]
35. Efficacy of miconazole in the topical treatment of tinea pedis in sportsmen. Gentles JC, Jones GR, Roberts DT. Br J Dermatol; 1975 Jul 01; 93(1):79-84. PubMed ID: 1103934 [Abstract] [Full Text] [Related]
36. Topical treatment for moccasin-type tinea pedis. Greer DL. J Am Acad Dermatol; 1987 Mar 01; 16(3 Pt 1):554-8. PubMed ID: 3546420 [Abstract] [Full Text] [Related]
37. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study. Watanabe S, Takahashi H, Nishikawa T, Takiuchi I, Higashi N, Nishimoto K, Kagawa S, Yamaguchi H, Ogawa H. Mycoses; 2007 Jan 01; 50(1):35-40. PubMed ID: 17302746 [Abstract] [Full Text] [Related]
38. [Treatment of skin diseases with mycopol]. Steppert A. Wien Med Wochenschr; 1966 Apr 02; 116(14):307-9. PubMed ID: 4229094 [No Abstract] [Full Text] [Related]
40. Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems. AbouSamra MM, Salama AH. J Liposome Res; 2017 Dec 02; 27(4):324-334. PubMed ID: 27666873 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]